Our offerings under Regulation D Rule 506(c) are available to accredited investors only.
GENERALLY, NO SALE MAY BE MADE TO YOU IN THIS OFFERING IF THE AGGREGATE PURCHASE PRICE YOU PAY IS MORE THAN 10% OF THE GREATER OF YOUR ANNUAL INCOME OR NET WORTH. DIFFERENT RULES APPLY TO ACCREDITED INVESTORS AND NON-NATURAL PERSONS. BEFORE MAKING ANY REPRESENTATION THAT YOUR INVESTMENT DOES NOT EXCEED APPLICABLE THRESHOLDS, WE ENCOURAGE YOU TO REVIEW RULE 251(D)(2)(I)(C) OF REGULATION A. FOR GENERAL INFORMATION ON INVESTING, WE ENCOURAGE YOU TO REFER TO WWW.INVESTOR.GOV

What Orthotics Should Professional Athletes Wear? – David C. Karli

In this Show

David C. Karli interviews Brad Layzell, CEO of PX3 Sports Sciences. PX3 is an innovative breathing orthotic that has been in development in multiple sectors, including sports medicine/injury prevention, wellness, fitness, neurosciences, sleep and human performance sectors. PX3 orthotics are worn by many professional and elite level athletes. Brad discusses PX3 company development from an entrepreneur perspective and the challenges associated with developing a disruptive technology. PX3 products are positioned for growth and significant commercialization and sales with a sound R&D platform and IP portfolio.

Get in contact with David C. Karli through his website, LinkedIn, and learn more about Greyledge Technologies here:

davidkarli.com

https://www.linkedin.com/in/davidkarli/

https://www.greyledgebiotech.com/

(Visited 3 times, 1 visits today)